Who We Are

ADDICTION RESEARCH INSTITUTE ENGAGES
DR. I JEAN DAVIS TO JOIN BOARD LEADERSHIP

 



SAN DIEGO - January 27th, 2021 - The Addiction Research Institute, announced today the appointment of Dr. I Jean Davis to the board of directors. “We are delighted to announce the appointment of Dr. I Jean Davis to the Addiction Research Institute board of directors. She brings with her a unique perspective on wellness, behavioral and mental health and inclusion,” said Gene Barduson, founder of The Addiction Research Institute.

Dr. I Jean Davis has decades of experience as a community advocate, educator, clinician, and researcher. Her extensive education includes a BA in Psychobiology, a BS in Human Biology, an MS in Clinical Research, a Doctoral degree in Chiropractic Medicine, and a PhD in Preventative Medicine. She is widely known and recognized for her education, research, and expertise as a primary care provider, Associated Professor, Internal Medicine at Charles Drew University of Medicine and Science, Past Medical Director and HIV Clinician at AIDS Health Foundation-Desert AIDS Project, and as a Clinician at Dusk to Dawn Urgent Care.


She completed an Integrated Health and Medicine Fellowship at the Academy of Integrated Health and Medicine (AIHM). Dr. Davis is the AIHM Black, Indigenous, and People of Color Task Force Co-Chair. She’s a current Board Member of the Beyond AIDS Foundation at AIHM and a member of the AAHIVM CA/HI Steering Committee.


Dr. Davis shared, “I plan to utilize my healthcare experience to make sure we look at solutions from both a medical and psycho-social point of view.” Her continued focus is on total health and the reduction of disorders and diseases which disproportionately impact underserved communities and related social determinants. These health disparities include but are not limited to HIV/AIDS, Cancer, Cardiovascular Disease, Substance Abuse, Diabetes, and Renal Disease.


Dr. Davis’ previous experience in how progressive research can optimize disease treatment over time aligns clearly with the work The Addition Research Institute is focused on accomplishing.

To learn more about The Addiction Research Institute or to donate visit them at www.addictionresearchinstitute.org. The organization is also inviting those who’ve been impacted with addiction to share their story by submitting here. For ongoing updates, follow ARI on Facebook or sign up for updates here. Initial funding for The Addiction Research Institute has been provided by the Farrell Family Foundation.


About Addiction Research Institute 

The Addiction Research Institute exists to fund profound breakthroughs to cure addiction. The Addiction Research Institute’s (ARI’s) SOLE focus is on funding research to cure the disease of addiction. Shockingly, there is no significant private funding to advance treatment and cures for alcohol and drug addiction. With the /current status of research, there is only a 2% chance of remission from this disease. We are here to fuel breakthroughs that will dramatically improve the lives of all those afflicted with alcohol and drug addiction, and the lives of their families.


###


MEDIA CONTACT: 

Angela Baldwin

Baldwin PR and Marketing 

angela@baldwinprandmarketing.com 

650-270-3082


Our Vision

Addiction Research Institute vision is to dramatically improve the lives of all those afflicted with alcohol and drug addiction, and the lives of their families, with profound breakthroughs to cure the disease of addiction.

Gene Barduson

Founder and Board Member

Gene is the Founder of the Addiction Research Institute. He served as CEO and board chairman for several healthcare companies, as well as a member of the board of trustees at Western University of Health Sciences, and currently serving on the Board Of Trustees at Scripps Health System. He received his bachelor’s degree in mathematics from St. Cloud State University in Minnesota, and his master’s degree in mathematics from the University of Northern Iowa. Honorary Doctorate Degree of Letters, LHD (HON) from Western University of Health Sciences.

Mike Dusoe

Board Member

Mike is a licensed Psychotherapist focused on providing individual and couples counseling services. Specializing in work-related stress, substance abuse services, trauma, and mood disorders. 


He is the founder and operator of a successful mental health clinic and consulting company while also being an educator at the University of Utah and University of Phoenix, teaching graduate-level mental health coursework.

Dave Baron

Board Member

David Baron, DO, MSEd, is Senior Vice President and Provost of the Western University of Health Sciences and serves as Chief Academic Officer of the university. He is responsible for academic, accreditation, and budgetary affairs. Dr. Baron joined the university in May 2018 after serving for eight years in roles within the Department of Psychiatry at the Keck School of Medicine, including Vice Dean for Global Health, Professor of Psychiatry and Neurosurgery, Vice Chair of the Department, and Chief of Service at Keck-USC Hospital.

He received his DO degree from the Philadelphia College of Osteopathic Medicine (PCOM) and a Master of Science in Education from the University of Southern California (USC). He is the former Deputy Clinical Director of the National Institute of Mental Health (NIMH), former President of the American College of Neuropsychiatry and the Group for the Advancement of Psychiatry, and chaired the Department of Psychiatry at Temple University School of Medicine from 1998-2010.

Dr. Baron was named a National Fulbright scholar in 2017-18 and conducted his research as Distinguished Chair in Brain Research at the University of Calgary. He also is the recipient of a Fulbright Specialist Award.

Howard B. Moss, M.D.

Board Member​

Howard B. Moss, M.D. is currently Clinical Professor of Psychiatry and Neuroscience at the University of California at Riverside School of Medicine, as week as Clinical Professor of Psychiatry at University of California San Diego. He is the former Associate Director for Clinical and Translational Research at the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health in Bethesda, Maryland. Dr. Moss is a board-certified addiction and general psychiatrist.  For the past 30 years, Dr. Moss has been a key opinion leader in addiction psychiatry and in the evidence-based clinical management of individuals with substance use disorders complicated by psychiatric comorbidity, Previously, he has been Professor of Psychiatry at University of Pennsylvania, Temple University, and the University of Pittsburgh prior to assuming his role at the National Institute of Health.  His research has focused on the clinical manifestations of substance use disorders, their etiology, and the intergenerational transmission of risk and resilience.  This work has employed diverse methodologies that include psychiatric epidemiology, advanced statistical methods, neurochemistry/neuropharmacology, psychophysiology, biomarker development, neuroimaging, and molecular and behavioral genetics. He has authored over 200 peer-reviewed scientific journal publications and three books.  He has also mentored numerous medical students, residents, fellows, and academic faculty in the conceptualization, development and conduct of addiction-related research protocols, as well providing didactic lectures to trainees at various stages of their academic training. Dr. Moss now resides in La Jolla, California.

IMG_1496

Jackie Hartman

Board Member

Jackie is a grassroots advocate who for the past five years has been in the trenches battling the obstacles faced by those with addiction and mental illness. Her approach focuses on prevention, education, and solutions. Like many others, she has lived experience with the challenges and suffering faced by individuals and their families in the world of addiction and mental illness.

Throughout her career, she worked as a management consultant and project manager for both large publicly held companies and government agencies. She also held quality and operations management positions at a large privately held corporation. Her expertise is in process improvement, cost reduction, quality, and training.

She earned a bachelor’s degree in public health from the University of Minnesota – Minneapolis and continued graduate work in business administration.

Bill Kliewer

Advisor

Bill pioneered the development of global fund-raising programs in the emerging countries of Korea, Taiwan, Hong Kong, Thailand, India and other developing nations. He helped raise an additional $150 million to feed those who were starving during the Ethiopia famine. Bill has a vision and passion for helping grow charitable enterprises especially in the area of fundraising.

Scott Swartzwelder, Ph.D

Chief Researcher Advisor

Dr. Scott Swartzwelder is a clinical psychologist and neurobiologist and is a Professor of Psychiatry and Behavioral Sciences and Psychology and Neuroscience at Duke University. 

His laboratory studies the effects of alcohol and other drugs on the brain, particularly on brain mechanisms of learning, memory, and affect during adolescence and early adulthood. His clinical work has focused on the assessment and treatment of Veterans and other patients with substance abuse disorders and cognitive dysfunction. He has published over 200 scientific papers, written four books translating the science of drug actions into lay language, and has trained more than 70 scientists and clinician-scientists.

In addition, he has created and taught several innovative college courses on brain mechanisms of memory and drug effects and has consulted extensively as a scientific advisor for multiple national institutes, federal departments, and public education and policy organizations. He was the lead content developer for AlcoholEdu, which millions of U.S. college students have used. 

He is a recent recipient of the Bowles Award for distinguished contributions to the understanding of the causes, prevention, and treatment of alcohol use disorder and alcohol abuse.

Mike Armistead

Board Member

Armistead’s career has spanned over three decades of leadership roles in the cyber security, software development and consumer internet arenas. He is currently Director Outbound Product Management at Google Cloud Security. Armistead was formerly SVP Products at Mandiant, having joined their management team in 2020 with the acquisition of Respond Software, which he co-founded and led as CEO since 2016. Previously, Armistead co-founded Fortify Software in 2003 and acted as VP & general manager for both Fortify and ArcSight business groups after the companies were acquired by HP in 2011. Prior to Fortify, Armistead held executive and key product positions at companies that include Pure Atria (IBM Rational) and Lycos.

Over his career, Armistead has led groups in all aspects of the organization, including marketing, development, operations and sales. His experience has spanned from managing large enterprises (+$350M revenues) to multiple start-ups in numerous industries.

Jean Davis, Ph.D

Advisor

Dr. I Jean Davis has decades of experience as a community advocate, educator, clinician, and researcher. Her extensive education includes a BA in Psychobiology, a BS in Human Biology, an MS in Clinical Research, a Doctoral degree in Chiropractic Medicine, and a PhD in Preventative Medicine. She is widely known and recognized for her education, research, and expertise as a primary care provider, Associated Professor, Internal Medicine at Charles Drew University of Medicine and Science, Past Medical Director and HIV Clinician at AIDS Health Foundation-Desert AIDS Project, and as a Clinician at Dusk to Dawn Urgent Care.